Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Ternium Raises Provision for Usiminas Acquisition Lawsuit to $619.1 Million

Ternium Raises Provision for Usiminas Acquisition Lawsuit to $619.1 Million

BitgetBitget2026/11/04 11:59
  • Ternium’s provision for litigation over its 2012 Usiminas stake acquisition reached $619.1 million at September 30, 2026, up $91.5 million.
  • Brazil’s Superior Court of Justice ordered indemnification to CSN, reversing its earlier rejection of the claim in June 2024.
  • CSN alleges the buyers were required to launch a tender offer for minority shareholders’ ordinary shares.
  • An appeal remains pending before the Supreme Federal Tribunal following dismissal of a separate appeal on November 26, 2025.
  • The steelmaker maintains CSN’s claims lack merit and seeks reversal of the indemnification rulings.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ternium SA published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001342874-26-000052), on November 04, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Dental treatment company vVardis has announced the terms for its $214 million US IPO.

智通财经•2026/11/09 06:41
"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss

Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.

智通财经•2026/11/09 06:41
Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss